AMA creates online Zika virus resource center for physicians and patients

In an effort to better educate doctors and their patients about the Zika virus, the American Medical Association (AMA) announced today the creation of the Zika Virus Resource Center.

The online tool is designed to be a “clearinghouse for timely, credible information from the CDC, other respected health organizations, and The Journal of the American Medical Association,” the AMA said. 

The recent outbreak of the mosquito-borne virus, which is linked to microcephaly and other neurological abnormalities in developing fetuses, has been declared an international public health emergency by the World Health Organization, with thousands of cases now confirmed in 25 countries.

“With global infection rates of the Zika virus increasing rapidly, physicians should be prepared to handle possible cases of the virus and answer patients’ questions,” according to the resource center homepage. “No locally transmitted Zika virus cases have been reported in the continental United States, but cases have been confirmed in returning travelers.”

The website includes links to resources for the public, such as prevention information for pregnant women, maps of infected areas and answers to frequently-asked questions, as well as resources for physicians, including clinical guidance and Zika virus research.

“The American Medical Association is ensuring that physicians are prepared to respond to patients' concerns about this mosquito transmitted disease,” the AMA said in the announcement.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.